Canada markets closed

NOXXON Pharma N.V. (ALNOX.PA)

Paris - Paris Delayed Price. Currency in EUR
Add to watchlist
0.2392-0.0050 (-2.05%)
At close: 05:26PM CET
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2020-12-31
2019-12-31
2018-12-31
Total Revenue
0
0
0
0
Cost of Revenue
-
-
1,029
982
Gross Profit
-
-
-1,029
-982
Operating Expenses
Research Development
7,982
4,017
496
479
Selling General and Administrative
1,049
912
1,320
1,292
Total Operating Expenses
9,744
5,751
2,915
3,337
Operating Income or Loss
-9,744
-5,751
-3,944
-4,319
Interest Expense
1,850
5,055
3
6,758
Income Before Tax
-11,244
-10,406
-860
-10,737
Income Tax Expense
0
0
1
1
Income from Continuing Operations
-11,244
-10,406
-861
-10,738
Net Income
-11,243
-10,405
-861
-10,734
Net Income available to common shareholders
-11,243
-10,405
-861
-10,734
Basic EPS
-
-0.32
-0.08
-2.70
Diluted EPS
-
-0.32
-0.08
-2.70
Basic Average Shares
-
32,359
11,158
3,979
Diluted Average Shares
-
32,359
11,158
3,979
EBITDA
-
-5,288
-810
-3,956